| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8f607aae0c385788440eb507e1e75c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055ca0801acbd0789725255c35ee337e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52a65dfce281ef252539afc6a49dc38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb01dac081431ddf623234acc486162c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576bfa56d91064d462f22461f1f1e0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0392edfd38121343c7827103858db25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c328f86967b8caf92e9e3105ef5102eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa6252e6b866246f81ea664bc6dc65a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1137693057bd3d0552760b160d9e72a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97d6a6d548dab931fb43cda1b16a8582 |
| publicationDate |
2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017171548-A1 |
| titleOfInvention |
Detection of cancer in urine |
| abstract |
The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108410989-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108441561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021172029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020013693-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108866196-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108060231-A |
| priorityDate |
2016-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |